<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7264656\results\search\testTrace\results.xml">
  <result pre="known knowledge regarding epidemiological, pathogenesis, pathology, clinical features, comorbidities and" exact="treatment" post="of COVIDâ€�19/ SARSâ€�CoVâ€�2 as reference for the prevention and"/>
  <result pre="fish and live wild animals.2 The subsequent evidence of clinician" exact="infection" post="suggests that SARSâ€�CoVâ€�2 can transmit from human to human.3"/>
  <result pre="T cells are also changed in severe patients.2, 4 Many" exact="diagnosis" post="and treatment strategies have been taken to prevent the"/>
  <result pre="are also changed in severe patients.2, 4 Many diagnosis and" exact="treatment" post="strategies have been taken to prevent the spread of"/>
  <result pre="have been taken to prevent the spread of SARSâ€�CoVâ€�2 and" exact="isolation" post="is the most effective way. Detection of SARSâ€�CoVâ€�2 nucleic"/>
  <result pre="a convenient way to identify COVIDâ€�19. For hospitalized patients, drug" exact="treatment" post="such as alpha interferon, lopinavir/ritonavir, ribavirin, chloroquine phosphate and"/>
  <result pre="to describe the epidemiological, pathogenesis, pathology, clinical features, comorbidities and" exact="treatment" post="of COVIDâ€�19/SARSâ€�CoVâ€�2. 2 EPIDEMIOLOGY So far, the COVIDâ€�19 patients"/>
  <result pre="greatly to the viral classification and traceability, rapid nucleic acid" exact="detection" post="of patients and understanding of the mechanism of viral"/>
  <result pre="detection of patients and understanding of the mechanism of viral" exact="infection" post="and transmission. Especially, the clear viral sequence data could"/>
  <result pre="factor, and a lot of research have disclosed that higher" exact="prevalence" post="of COVIDâ€�19 in men than women.48 It may be"/>
  <result pre="and SARSâ€�CoV, which showed O blood group with a lower" exact="infection" post="chance and antiâ€�A antibodies specifically inhibit the adhesion of"/>
  <result pre="I (hsâ€�cTnI) was increased substantially in five patients with the" exact="diagnosis" post="of virusâ€�related cardiac injury. Four out of the five"/>
  <result pre="of patients have proteinuria haematuria, 26.9% have haematuria and the" exact="prevalence" post="of elevated serum creatinine and blood urea nitrogen were"/>
  <result pre="associated with disease severity.2 7 DETECTION METHODS 7.1 Nucleic acid" exact="detection" post="Detect SARSâ€�CoVâ€�2 nucleic acid by realâ€�time RTâ€�PCR via designing"/>
  <result pre="in consideration of the specific sequence of SARSâ€�CoVâ€�2, realâ€�time RTâ€�PCR" exact="detection" post="of ORF1ab and N genes is recommended widely. If"/>
  <result pre="be detected. Normally, the N gene is recommended as a" exact="screening" post="assay and the ORF1ab assay as a confirmatory one."/>
  <result pre="reference laboratory.65 In addition to ORF1ab and N genes, the" exact="detection" post="of S gene is also considered by many laboratories."/>
  <result pre="S gene is also considered by many laboratories. Nucleic acid" exact="detection" post="technology has the characteristics of early diagnosis, high sensitivity"/>
  <result pre="or blood specimens (TableÂ 1). Table 1 The changes of" exact="nucleic acid test" post="and serological test in the Diagnosis and Treatment Guideline"/>
  <result pre="23) Ver 2 (Jan 18) Laboratory test 1. Aetiological test:" exact="nucleic acid test" post="in the specimens of pharyngeal swab, sputum and other"/>
  <result pre="The suspected cases should be isolated and introduced for multidiscipline" exact="diagnosis" post="within 2h; If necessary, they should be tested for"/>
  <result pre="acid of SARSâ€�CoVâ€�2. The suspected case can be excluded if" exact="nucleic acid test" post="is negative in two consecutive times (the interval of"/>
  <result pre="of sampling time is at least 1Â day). Release from" exact="quarantine" post="The outâ€�ofâ€�hospital standard: Nucleic acid test is negative in"/>
  <result pre="version. (C) John Wiley &amp;amp; Sons, Ltd, Although the viral" exact="nucleic acid test" post="is currently the standard method for diagnosis of COVIDâ€�19,"/>
  <result pre="viral nucleic acid test is currently the standard method for" exact="diagnosis" post="of COVIDâ€�19, the obvious limitations restrict its extensive use:"/>
  <result pre="technology developed ultraâ€�fast DNA or RNA amplification, combined with fluorescence" exact="detection" post="system based on the nicking endonuclease amplification reaction (NEAR)"/>
  <result pre="15Â minutes). This technology will substantially speed up the population" exact="screening" post="and COVIDâ€�19 patient identification.67 7.2 Antibody detection Rapid and"/>
  <result pre="up the population screening and COVIDâ€�19 patient identification.67 7.2 Antibody" exact="detection" post="Rapid and accurate detection of SARSâ€�CoVâ€�2â€�specific antibodies in the"/>
  <result pre="and COVIDâ€�19 patient identification.67 7.2 Antibody detection Rapid and accurate" exact="detection" post="of SARSâ€�CoVâ€�2â€�specific antibodies in the blood of patients is"/>
  <result pre="Moreover, positive IgM antibody often indicates an acute phase of" exact="infection" post="while positive IgG antibody indicates late or previous infection."/>
  <result pre="antibody indicates late or previous infection. Therefore, we believe that" exact="detection" post="of IgM and IgG can also provide information on"/>
  <result pre="can be considered as a complementary way for nucleic acid" exact="detection" post="and could also help to diagnose the COVIDâ€�19 patient"/>
  <result pre="help to diagnose the COVIDâ€�19 patient with negative result of" exact="nucleic acid test" post="but positive antibody.70 In addition, antibody test could be"/>
  <result pre="tissue,74, 75 which will become a new exploration in the" exact="treatment" post="of severe COVIDâ€�19. It also brings new hope for"/>
  <result pre="of severe COVIDâ€�19. It also brings new hope for the" exact="treatment" post="of novel coronavirus infectionâ€�related acute respiratory distress syndrome. A"/>
  <result pre="Wang et al 2020 In vitro Favipiravir could suppress SARSâ€�COVâ€�2" exact="infection" post="at a high concentration Remdesivir Holshue etÂ al 2020"/>
  <result pre="et al 2020 In vitro Arbidol can effectively inhibit SARSâ€�CoVâ€�2" exact="infection" post="at a concentration of 10â€�30Â ÂµM Nitazoxanide Wang et"/>
  <result pre="rate and the use of methylprednisolone when introduced as a" exact="treatment" post="of SARS patients in early stage.76, 77 A recent"/>
  <result pre="lopinavir/ritonavir indicated that no benefit effect was observed after lopinavir/ritonavir" exact="treatment" post="beyond standard care in hospitalized severe COVIDâ€�19 patients.79 Disulfiram"/>
  <result pre="hospitalized severe COVIDâ€�19 patients.79 Disulfiram is a drug for the" exact="treatment" post="of alcohol dependence, and studies have confirmed its inhibitory"/>
  <result pre="viruses.80 A recent study demonstrated that Favipiravir could suppress SARSâ€�CoVâ€�2" exact="infection" post="at a high concentration (halfâ€�maximal effective concentration (EC50)Â =Â"/>
  <result pre="&amp;gt;400Â Î¼mol/L, selectivity index (SI)&amp;gt; 6.46).81 Remdesivir, approved for HIV" exact="infection" post="treatment, has been used to cure a COVIDâ€�19 patient"/>
  <result pre="vitro study has revealed that Arbidol could effectively inhibit SARSâ€�CoVâ€�2" exact="infection" post="at a concentration of 10â€�30Â Âµmol/L, which brought arbidol"/>
  <result pre="recovery patients was recommended by WHO as one of the" exact="treatment" post="modalities.97 In 2015, the laboratory effect of convalescent plasma"/>
  <result pre="plasma therapy for patients with Middle East respiratory syndrome coronavirus" exact="infection" post="was reported98 and no severe adverse events occurred among"/>
  <result pre="al. Clinical characteristics and intrauterine vertical transmission potential of COVIDâ€�19" exact="infection" post="in nine pregnant women: a retrospective review of medical"/>
  <result pre="20HuangR, XiaJ, ChenY, ShanC, WuC. A family cluster of SARSâ€�CoVâ€�2" exact="infection" post="involving 11 patients in Nanjing. Lancet Infect Dis. 2020."/>
  <result pre="application of a rapid IgMâ€�IgG combined antibody test for SARSâ€�CoVâ€�2" exact="infection" post="diagnosis. J Med Virol. 2020. 67KanwarN, MichaelJ, DoranK, MontgomeryE,"/>
  <result pre="Xpress Flu pointâ€�ofâ€�care nucleic acid amplification tests for influenza A/B" exact="virus detection" post="in children. J Clin Microbiol. 2020;58(3). 68RacineR, WinslowGM. IgM"/>
  <result pre="Flu pointâ€�ofâ€�care nucleic acid amplification tests for influenza A/B virus" exact="detection" post="in children. J Clin Microbiol. 2020;58(3). 68RacineR, WinslowGM. IgM"/>
  <result pre="Infect. 2020;9(1):386â€�389.32065057 70LiH, PanJ, SuY, WangB, GeJ. SARSâ€�CoVâ€�2 lgM/lgG antibody" exact="detection" post="confirms the infection after three negative nucleic acid detection."/>
  <result pre="PanJ, SuY, WangB, GeJ. SARSâ€�CoVâ€�2 lgM/lgG antibody detection confirms the" exact="infection" post="after three negative nucleic acid detection. J Cell Mol"/>
  <result pre="78KimJY, KoJH, KimY, et al. Viral load kinetics of SARSâ€�CoVâ€�2" exact="infection" post="in first two patients in Korea. J Korean Med"/>
  <result pre="J Med. 2020. 80De ClercqE. New nucleoside analogues for the" exact="treatment" post="of hemorrhagic fever virus infections. Chemistry. 2019;14(22):3962â€�3968. 81WangM, CaoR,"/>
  <result pre="TianZ, YangX. Breakthrough: Chloroquine phosphate has shown apparent efficacy in" exact="treatment" post="of COVIDâ€�19 associated pneumonia in clinical studies. Bioscience Trends."/>
  <result pre="88GautretP, LagierJC, ParolaP, et al. Hydroxychloroquine and azithromycin as a" exact="treatment" post="of COVIDâ€�19: results of an openâ€�label nonâ€�randomized clinical trial."/>
  <result pre="Ther. 2020;5:18.32296012 93RichardsonP, GriffinI, TuckerC, et al. Baricitinib as potential" exact="treatment" post="for 2019â€�nCoV acute respiratory disease. Lancet. 2020;395(10223):e30â€�e31.32032529 94ZhangDH, WuKL,"/>
  <result pre="disease. Lancet. 2020;395(10223):e30â€�e31.32032529 94ZhangDH, WuKL, ZhangX, DengSQ, PengB. In silico" exact="screening" post="of Chinese herbal medicines with the potential to directly"/>
  <result pre="Infect Dis. 2005;24(1):44â€�46.15616839 96HungIF, ToKK, LeeCK, et al. Convalescent plasma" exact="treatment" post="reduced mortality in patients with severe pandemic influenza A"/>
  <result pre="Science (New York, NY). 2016;352(6288):1001â€�1004. 100collab: China. NHCotPsRo . Clinical" exact="treatment" post="program of convalescent plasma in recovering patients with COVIDâ€�19"/>
 </snippets>
</snippetsTree>
